Histoplasmosis is one of three dimorphic mycoses researchers identified as having expanded beyond their historic “areas of endemicity” in the U.S. Image: Adobe Stock.

Emerging Infectious Diseases (2023). [2] Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects. Frontiers in Medicine (2021).